Team:NRP-UEA-Norwich/Results/Prebiotic
RESULTS
Making constructs to express inducible branching and debranching enzymes in E. coli
AIM:
We aimed to ligate the E. coli glycogen metabolic genes GlgX and GlgB into the standard pSB1C3 plasmid vector with and without an IPTG-inducible promoter. GlgX is a glycogen debranching enzyme which cleaves α-1,6 glycosidic linkages in glycogen to remove branches. GlgB is a glycogen branching enzyme which cleaves α-1,4 glycosidic linkages and re-anneals the cleaved linkage back onto the main chain through an α-1,6 linkage, therefore creating a branch. Creating parts with the promoter allows us to investigate the effect of the expression of these enzymes on E. coli glycogen in an inducible system. Basic parts with just the enzyme coding sequences were also generated so that they can be used to build other composite parts in the future.
METHOD:
To achieve the cloning, we digested the various DNA components (GlgX or GlgB sequence, pSB1C3 and IPTG-inducible promoter) according to the restriction digest protocol with the relevant restriction enzymes to create compatible ends. The digestions were then run on an agarose gel and gel extracted to yield the digested DNA components. These were ligated and transformed into competent E. coli DH5α cells. A colony PCR was undertaken and liquid cultures of colonies with the correctly-sized inserts were prepared. The plasmids were purified by plasmid prep and sent for sequencing. After sequencing a mutation in the terminator codon of the GlgX sequence was discovered and this was subsequently corrected with mutagenesis PCR to give the correct sequence.
RESULTS:
The resulting plasmids were GlgX with IPTG-inducible promoter, GlgX without IPTG-inducible promoter, GlgB with IPTG-inducible promoter, and GlgB without IPTG-inducible promoter.
Figure 1 shows gel electrophoresis of PCR products of GlgB inserted into the backbone without the LacI promoter and RBS. Lane 1-Ladder, 2 – 11 putative codes of GlgB without promoter, Lane 12-16- putative codes of GlgB with promoter, Lane 17 – no template control, Lane 18- RFP positive control, Lane 19- Ladder. The GlgB CDS is 2231 base pairs the PCR bands is just above the 2000 bp marker. Sanger sequencing of a putative positive clones confirmed the correct insertion in wells 5, 8, 9, 10, 11, 14, and 16.
Figure 1
Figure 2 shows gel electrophoresis of PCR products of GlgX inserted into the backbone with the LacI promoter and RBS. Lane 1-Ladder, 2 – no template control, Lane 3- RFP positive control, Lane 4-13 – putative codes of GlgX with promoter, Lane 14- Ladder. The GlgX CDS is 2019 base pairs the PCR bands is just above the 2000 bp marker. Sanger sequencing of a putative positive clones confirmed the correct insertion in wells 5, 9 and 10.
Figure 2
Figure 3 shows gel electrophoresis of PCR products of GlgX inserted into the backbone without the LacI promoter and RBS. Lane 1-Ladder, 2– no template control, Lane 3- RFP positive control, Lane 4-6 – bacterial cell controls, Lane 7-14 - putative codes of GlgX without promoter, Lane 15- Ladder. The GlgX CDS is 2019 base pairs the PCR bands is just above the 2000 bp marker. Sanger sequencing of a putative positive clones confirmed the correct insertion in wells 7 through 14.
Figure 3
Making constructs to express putative α-glucan acyltransferases in E. coli
AIM:
To ligate four putative α-glucan acyltransferase genetic sequences: MAO, Rv3030, Rv3034c, and Rv3037c into the standard pSB1C3 plasmid vector with and without an a LacI promoter.
METHOD:
We digested DNA components (putative acyltransferase sequences, pSB1C3 with LacI promoter and RBS) according to the restriction digest protocol with the relevant restriction enzymes to create compatible ends. The digestions were then run on an agarose gel and gel extracted to yield the digested DNA components. These were ligated and transformed into competent E. coli DH5α cells. Putative clones were screened by colony PCR and liquid cultures of colonies with the correctly-sized inserts were prepared. The plasmids were purified by plasmid prep and sent for sequencing.
RESULTS:
The resulting plasmids were MAO with LacI promoter and RBS, MAO, Rv3030 with IPTG-inducible promoter, Rv3030, Rv3034c LacI promoter and RBS, Rv3034c, Rv3037c LacI promoter and RBS and Rv3037c.
Figure 1 shows gel electrophoresis of PCR products of Rv3030 inserted into the backbone without the LacI promoter and RBS. Lane 1- Ladder, Lane 2- no template control, Lane 3- positive RFP control, Lanes 4-6- putative MAO clones which were contaminated with RFP, Lanes 7-9- putative Rv3030 clones. Sanger sequencing of a putative Rv3030 (with size 850 bp) positive clone confirmed the correct insertion in wells 1 and 3.
Figure 1
Figure 2 shows gel electrophoresis of PCR products of MAO, Rv3034c and Rv3037c inserted into the backbone without the LacI promoter and RBS. Lane 1- Ladder, Lane 2- positive RFP control, Lane 3- no template control, Lanes 4-6- putative MAO clones, Lanes 7-9- putative Rv3034c clones, Lanes 10-14- putative Rv3037c clones, Lane 15- Ladder. Sanger sequencing of a putative MAO (with size 600 bp), Rv3034c (with size 950 bp), and Rv3037c (with size 1110) positive clones confirmed the correct insertion in wells 4 through 14.
Figure 2
Figure 3 shows gel electrophoresis of PCR products of MAO, Rv3030 and Rv3034c inserted into the backbone with the LacI promoter and RBS. Lane 1- Ladder, Lane 2- positive RFP control, Lane 3- no template control, Lanes 4-6- putative MAO clones, Lanes 7-9- putative Rv3030 clones, Lanes 10-12- putative Rv3034c clones, Lane 13-15- unsuccessful Rv3037c clones, Lane 16- Ladder. Sanger sequencing of a putative MAO (with size 600 bp), Rv3030 (with size 850 bp), and Rv3034c (with size 950 bp) positive clones confirmed the correct insertion in wells 4 through 12.
Figure 3
Figure 4 shows gel electrophoresis of PCR products of Rv3037c inserted into the backbone with the LacI promoter and RBS. Lane 1-5 putative Rv3037c clones, Lane 6- Ladder. Sanger sequencing of a putative Rv3037c (with size 1110 bp) positive clones confirmed the correct insertion in wells 1 through 5.
Figure 4
Determining if expression of glycogen branching and debranching enzymes affect E. coli glycogen content
AIM:
To analyse the effect of GlgX (glycogen debranching enzyme) and GlgB (glycogen branching enzyme) expression on glycogen content in E. coli. We initially set out to investigate by looking at the staining of whole-cell extracts with Lugol’s solution. The iodine in the Lugol’s solution intercalates in the glucan chains to give a coloured complex. Comparison between the colours observed can give an indication of the amount and branching structure of the glycogen within the sample1.
METHOD:
Competent E. coli were transformed with Biobricks expressing GlgX or GlgB under the control of the LacI promoter and firstly grown in 10 mL LB media overnight at 37 °C with shaking. Each culture was used to inoculate 2 x 10 mL of fresh media, grown to an OD of approximately 0.6 and then IPTG was added to one of each duplicate culture and the cultures continued to grow, with samples taken after 1 hour, 3 hours and overnight. At each timepoint a 1 mL extract was taken, spun down to pellet the cells and this pellet was re-suspended in Lugol solution, similar to a method previously been used by the the Edinburgh 2008 iGEM team.
The expected colour upon Lugol addition to glycogen is a dark brown colour, however, as shown in Figures 1-5, no sample has turned this colour with the majority of the colour seen identical to the orange/yellow of Lugol itself. We therefore repeated this method with nitrogen-limited, carbon rich minimal media M9 minimal media, which had previously been shown to lead to the accumulation of bacterial glycogen2.
Cells grew very slowly under these conditions and only reached an OD of approximately 0.6 after 24 hours.
RESULTS:
Figures 1 -5 show images of pelleted bacterial cells from LB media, resuspended in Lugol’s solution, and in every case it was not different to Lugol solution alone. 18 hours after induction The results from high carbon:nitrogen media are shown in Figure 5, in which every sample has a darker, browner colour than Lugol itself indicating a higher glycogen presence compared to LB media. Unfortunately solid particulates remaining in the samples precluded quantifying the results by measuring the absorbance with a spectrophotometer. Whilst there was clearly more glycogen in these samples, it was not possible to distinguish colour differences between the branching and debranching enzymes or between the IPTG-induced and non-induced samples. Therefore it was decided to extract the glycogen from the bacterial cells to analyse it directly.
Figure 1: Lugol’s control for colour comparison. This sample only contains Lugol’s solution.
Figure 2: The pelleted bacterial cells from 1 mL overnight LB cultures with no addition of IPTG re-suspended in 100 uL Lugol’s solution.
Figure 3: The pelleted bacterial cells from 1 mL of LB culture an hour after IPTG-addition re-suspended in 100 uL Lugol’s solution
Figure 4: The pelleted bacterial cells from 1 mL of LB culture 3 hours after IPTG-addition re-suspended in 100 uL Lugol’s solution
Figure 5: The pelleted bacterial cells from 1 mL of LB culture 18 hours after IPTG-addition, re-suspended in 100 uL Lugol’s solution. The lighter colours observed are due to solid particulates in the media.
References
1. Dreiling C, Brown D, Casale L, Kelly L. Muscle glycogen: Comparison of iodine binding and enzyme digestion assays and application to meat samples. Meat Science. 1987;20(3):167-177.
2. ANTOINE A, TEPPER B. Environmental Control of Glycogen and Lipid Content of Mycobacterium phlei. Journal of General Microbiology. 1969;55(2):217-226.
Determining if expression of glycogen branching and debranching enzymes affect E. coli glycogen content (2)
AIM:
To analyse the effect of GlgX (glycogen debranching enzyme) and GlgB (glycogen branching enzyme) expression on glycogen content in E. coli. As we were not able see any differences in whole-cell extracts we decided to extract the glycogen from the bacterial cells and analyse it directly.
METHOD:
E. coli transformed with inducible GlgB and GlgX were grown up in media that promoted the accumulation of glycogen as described in Glycogen Content 1 to give 1 L of induced and non-induced cultures for each construct. Glycogen was extracted from the cell pellet according to a glycogen extraction protocol, that we initially optimised for E. coli transformed with a control plasmid. This yielded an amorphous white solid that was confirmed to be glycogen by transmission electron microscopy (TEM). The weight of the solid was recorded and induced and non-induced samples were compared for each construct.
RESULTS:
•
Figure 1:
Figure 2:
Title
AIM:
METHOD:
RESULTS:
Figure 1:
Figure 2:
Title
AIM:
METHOD:
RESULTS:
Figure 1:
Figure 2:
Title
AIM:
METHOD:
RESULTS:
Figure 1:
Figure 2:
Making constructs to express putative acyltransferases in plant chloroplasts
AIM:
The aim of our prebiotic is to produce acylated/butrylated starch in plants. Methods to chemically acylate starch purified from plants already exist, but as they use strong chemicals and require heating they are not environmentally friendly. Using various acyltransferases, we hope to acylate starch in plants. We’ll be using a model plant, Nicotinia benthamiana, for initial tests because we can get results within a few days. Later on we’d aim to make transgenic plants in a species that makes a lot of starch such as maize (corn), potatoes or wheat.
METHOD:
We used Golden Gate Cloning and the Plant Standard Syntax1 to make our constructs. We used 35s promoter from Cauliflower Mosiac Virus (BBa_K1467101), to drive constitutive expression. We made a chloroplast transit peptide (New part - BBa_K1618028) that we then used in an N-terminal translational fusion with the acyl transferases for the protein to reach the chloroplast, where starch is produced.
In order to confirm that the transit peptide was functional we made a second set of constructs that had a fluorescent reporter in a C-terminal translational fusion.
To deliver the constructs to plants we needed to use Agrobacterium tumefaciens as a shuttle chassis. This meant parts needed to be assembled into a binary vector with origins of replication for both E.coli and A. tumefaciens. In order to submit the parts to the registry we also assembled parts into the MoCloFlipper pSB1C3 that accepts Golden Gate Parts into the pSB1C3 backbone.
All cloning was done according to the Golden Gate one-step Digestion-Ligation Protocol provided on our protocols page here.
Results:
Successful assembly into the binary vector.
Putative clones were screened by colony PCR (see Protocols for method - here) using primers that flank the insertion sites (Figure 1).
Figure 1: The gel lanes are as follows – 1 = Ladder, 2&3 = BBa_K1618033, 4&5 = BBa_K1618029, 6&7 = BBa_K1618035, 8&9 = BBa_K1618031, 10&11 = BBa_K1618036, 12&13 = BBa_K1618032, 14&15 = BBa_K1618034, 16&17 = BBa_K1618030, 18 = ladder. The gel image above indicated that the complete transcriptional units were successfully cloned.
A single colony for each construct was mini-prepped and sequenced before progression to transformation into A. tumefaciens.
Successful assembly into pSB1C3.
Putative clones were miniprepped (see Protocols for method - here) and screened by digestion with NotI (Figure 2) and also with EcoRI/Pstl (Figure 3) to confirm that cloning was successful and that our constructs had no internal BioBrick restriction sites.
Figure 2: The gel lanes are as follows – 1 = Ladder, 2&3 = BBa_K1618033, 4&5 = BBa_K1618029, 6&7 = BBa_K1618035, 8&9 = BBa_K1618031, 10&11 = BBa_K1618036, 12&13 = BBa_K1618032, 14&15 = BBa_K1618034, 16&17 = BBa_K1618030, 18 = ladder. These indicate that there are no unwanted internal Not1 restriction sites within our constructs.
Figure 3: The gel lanes are as follows – 1 = Ladder, 2&3 = BBa_K1618029, 4&5 = BBa_K1618031, 6&7 = BBa_K1618032, 8&9 = , 10&11 =BBa_K1618029, 12&13 = BBa_K1618031, 14&15 = BBa_K1618032, 16&17 = BBa_K1618030, 18 = Ladder. Lanes 2-9 were digested with Not1, while lanes 10-17 were digested with EcoR1/Pst1. The results indicate that the new tags allow our constructs to be BioBrick compatible.
A single colony for each construct was mini-prepped and sequenced before shipping to the registry.
References
1. Patron et al. (2015) Standards for Plant Synthetic Biology: A Common Syntax for Exchange of DNA Parts doi: 10.1111/nph.13532/full
Confirming the sub-cellular localisation of acyltransferases in plant chloroplasts
AIM:
To determine if our synthetic chloroplast transit peptide would direct the putative acyl trasnferases to the plant chloroplast. The aim of this experiment is to confirm that our constructs localise the acyl transferase to the plant chloroplast. In order for the enzymes that we have chosen to acylate starch, the enzymes need to reach the chloroplast of a cell as this is where starch is produced.
METHOD:
We transformed our binary vector constructs (see results “Making constructs to express putative acyl-transferases in plant chloroplasts” for the details of these constructs) containing the acyltransfeases with an N-terminal transit peptides and C-terminal fluorescent reporters into Agrobacterium tumefaciens by electroporation (see Protocols - here). Colonies were checked by PCR before liquid cultures were grown from individual colonies for infiltration of plant leaves (see Protocols - here). Finally, infiltrated leaves were examined by confocal microscopy to determine the subcellular localisation of the recombinant protein.
RESULTS:
Colonies of A. tumefaciens were screened by PCR to confirm the presence of the binary construct (Figure 1).
Figure 1: The gel lanes are as follows – 1 =BBa_K1618029 control, 2&3 = BBa_K1618029 Agrobacterium, 4 = BBa_K1618031 control, 5&6 = BBa_K1618031 Agrobacterium, 7 = Ladder, 8 = BBa_K1618032 control, 9&10 = BBa_K1618032 Agrobacterium, 11 = BBa_K1618030 control, 12&13 = BBa_K1618030 Agrobacterium, 14 = Ladder. The comparison between the agro-transformations and the sequence confirmed control suggests that the cloning was successful.
Leaves that had been infiltrated with A. tumefaciens strains containing our assembled binary constructs were images using an SP5 Leica confocal microscope (Figure 2). We used two channels: the first excites chlorophyll, which is shown in red and the second excites the fluorescent fusion protein (shown in yellow).
Figure 2: Constructs BBa_K1618029-032 contain a yellow fluorescent protein, as well as a chloroplast transit peptide. These are confocal microscopy images of the constructs infiltrated into Nicotiana benthamiana, in which the red structures are the chlorophyll within the chloroplast, and the yellow is the fluorescent fusion protein expressed from constructs (a) BBa_K1618029 (MAO enzyme), (b) BBa_K1618031 (RV3034c enzyme), (c) BBa_K1618032 (RV3037c enzyme), and (d) BBa_K1618030 (RV3030 enzyme).
Our results confirm that the putative acyltransferases are successfully localised to the chloroplasts of the plants.
Determining if the expression of acyl-transferases interferes with starch accumulation in plants
AIM:
To compare the starch content of leaves infiltrated with A.tumefaciens strains carrying constructs expressing our putative acyltransferases. A potential problem of using putative acyl transferases is that they will use the same C4 position of the glucose molecules that the starch synthases add new ADP-glucose units to, interfering with growth of the starch molecule. A simple test was to confirm that normal quantities of starch were being produced.
METHOD:
We transformed our binary vector constructs (see results “Making constructs to express putative acyl-transferases in plant chloroplasts” for the details of these constructs) containing the acyltransfeases with an N-terminal transit peptides into Agrobacterium tumefaciens by electroporation (see Protocols - here). Colonies were checked by PCR before liquid cultures were grown from individual colonies for infiltration of plant leaves (see Protocols - here).
Three plants were infiltrated with each experiment and control:- A. tumefaciens with no construct (control) - Strains of A. tumefaciens that contained each of the four binary vectors expressing putative acyltransferases. - The plants were of the same age, same species, and were grown in the same conditions..
After infiltration, the plants were left in a normal light/dark cycle at room temperature for 24 hours before being put in the dark for 24 hours. In the dark the plants would break down the stores of starch in their leaves.
After the dark treatment the samples from the infiltrated plants as well as control plants that had not been infiltrated were decolorized to remove the green chlorophyll and stained with iodine, which stains starch granules. A duplicate set of experiments was allowed to grow in the light for the rest of the day to build up new stores of starch. These were then assayed in the same manner to determine if expression of the putative acyltransferases interfered with starch accumulation.
RESULTS:
Colonies of A. tumefaciens were screened by PCR to confirm the presence of the binary construct (Figure 1).
Figure 1: The gel lanes are as follows – 1 = Ladder, 2 = BBa_K1618033 control, 3&4 = BBa_K1618033 Agrobacterium, 5 = BBa_K1618035 control, 6&7 = BBa_K1618035 Agrobacterium, 8 = Ladder, 9 = BBa_K1618036 control, 10&11 = BBa_K1618036 Agrobacterium, 12 = BBa_K1618034 control, 13&14 = BBa_K1618034 Agrobacterium. The comparison between the agro-transformations and the sequence confirmed control suggests that the cloning was successful.
After 24 hours in the dark the leaves from all samples were free of starch (Figure 2A). This allowed us to determine the amount of starch accumulated in the following 24 hours. Leaves sampled after 24 hours in the light all stained dark with iodine. There is no difference in the amount of staining observed in samples from leaves infiltrated with the A. tumefaciens strains that contained the binary vectors expressing putative acyl transferases as compared to the control samples (Figure 2B).
Figure 2: Iodine staining of leaves after (A) 24 hours dark treatment, and (B) dark treatment and 8 hours light treatment. The yellow samples, indicate that no starch is present - While there are black spots observed in some samples it is likely that these are due to damage from infiltration rather than starch. Black stain indicates the presence of starch. The level of staining doesn’t appear to differ between the different leaves and their conditions, suggesting that neither the infiltration process, or the expression of acyltransferases, affects starch production in leaves.
These results indicate that neither the infiltration process or the expression of putative acyl-transferases has an impact on the production of starch.
Cloning the Butyrate Biosynthetic Pathway - PART I
Our overall aim was to clone the coding sequences (CDSs) of the butyrate biosynthetic pathway from Coprococcus sp. L2-50 (DSM 16842) for expression in E.coli. In total the pathway contains eight coding sequences. We managed to clone the pathway that would convert butyrate into butyryl-CoA (Pathway I) and, separately, the pathway that would convert acetyl-CoA into butyryl-CoA (Pathway II).
Pathway I:
AIM:
To clone the CDSs from the BUK (butyrate kinase) and PTB (phosphotransbutyrylase) genes from Coprococcus sp. with an IPTG-inducible promoter. This BioBrick is designed catalyze the conversion of butyrate from/to butyryl-CoA. The PTB gene converts butyryl-CoA from/to butyryl-phosphate and the BUK gene converts butyrate-phosphate from/to butyrate.
METHOD:
The CDS of the PTB and BUK coding sequences were synthesised. We digested them from their shipping plasmids with XbaI and PstI. The pSB1C3 vector was digested with EcoRI and PstI and, the BioBrick with the LacI promoter and RBS with EcoRI and SpeI (See digestion protocol). The digests were run on an agarose gel and bands were gel extracted (See gel extraction protocol). The BUK CDS was ligated into the pSB1C vector together with the IPTG-inducible promoter and RBS and the PTB CDS was added to this BioBrick to make the final pathway (Figure 1). Transformation and colony screening was carried out as per our standard protocols). Putative clones were confirmed by sequencing.
Figure 1: Biobrick structure of the BUJK/PTB pathway with the IPTG-inducible promoter (lacI)
RESULTS:
Successful digestion and assembly of the CDSs of the PTB and BUK genes into the PSB1C3 vector with the LacI promoter and RBS.
In order to confirm that the gene inserts were successfully ligated, Colonies were screened by PCR (Figure 2). Putative clones were confirmed by Sanger sequencing.
Figure 2: Colony PCR products of BUK/PTB construct (lane 2-7) Primers used were BUK forward and VR. Expected size to be 1486 bp adding up to 1500 bp if considering promoter sequence.
Cloning the Butyrate Biosynthetic Pathway - PART II
Our overall aim was to clone the coding sequences (CDSs) of the butyrate biosynthetic pathway from Coprococcus sp. L2-50 (DSM 16842) for expression in E.coli. In total the pathway contains eight coding sequences. We managed to clone the pathway that would convert butyrate into butyryl-CoA (Pathway I) and, separately, the pathway that would convert acetyl-CoA into butyryl-CoA (Pathway II).
Pathway II:
AIM:
To clone the CDSs from the thiolase (THL), beta-hydroxybutyryl coenzyme A dehydrogenase (BHBD), Crotonase (CRO), Butyryl-CoA dehydrogenase (BCD), Electron Flavoprotein subunit a (EFa), and Electron Flavoprotein subunit b (EFb) genes from Coprococcus sp. with an IPTG-inducible promoter. This BioBrick should catalyze the conversion of acetyl-CoA to butyryl-CoA.
Figure 1: Schematic of the compound part with the coding sequences for THL/BHBD/CRO/BCD/EFb/EFa (BBa_K1618021)
METHOD:
The pSB1C3 vector was digested with EcoRI and PstI to add the LacI promoter and RBS, which was digested with EcoRI and SpeI (See digestion protocol). The digested plasmid was run on an agarose gel and the band was purified (See gel extraction protocol). The LacI-RBS part was ligated into the plasmid (See Ligation protocol) and then transformed into competent cells (See transformation protocol). The CDSs for each part of the pathway were inserted into this plasmid by digestion with SpeI and PstI and ligating in the CDSs that were released from their shipping plasmids with EcoRI and SpeI.
Colonies were screened by PCR (see colony PCR protocol) and putative clones were miniprepped and confirmed by sequencing.
RESULTS:
Successful digestion and assembly of 6 CDSs from the butyrate biosynthesis pathway into the PSB1C3 vector.
The six genes (THL, BHBD, CRO, BCD, EFb, EFa ) and the pSB1C3 vector with the Lacl promoter and RBS were digested. The expected sizes are: THL=1129 bp, BHBD=900 bp, CRO=836 bp, BCD=1211 bp, EFa=1100 bp, Efb=830 bp Figure 2 shows the successful release of parts form their backbones.
Figure 2: Agarose gel electrophoresis of restriction digestion of for the six genes of the butyrate pathway II released from their shipping plasmids as well as the backbones Lane 1=1KB Ladder, Lane 2 = pSB1C3 , Lane 3=LacI and RBS, Lane=4 PTB, Lane 5=THL, Lane 6=BCD, Lane 7=CRO, Lane 8=BHBD,Lane 9=EFa, Lane 10=EFb
Figure 3 shows colony PCR of the THL ligated to the LacI promoter and RBS. Primers used for colony PCR and sequencing were located in the plasmid vector backbone. Expected size of THL/PRO was 1500 bp.
Figure 3: Agarose gel electrophoresis of PCR products from a colony PCR of for addition of the THL CDS to the LacI promoter and RBS. Lane 1=1KB ladder. Lane 2-8 THL/Promoter samples. Only sample 4,6 and 8 were successful.
Figure 4 (A) shows colony of BHBD ligated to THL, the LacI promoter and RBS .Expected size was 1100 bp. Figure 4(B) shows the digest of a successful clone. It can be observed that the band size of the digest increases each time from the previous suggesting the addition of the new insert.
Figure 4: (A) Agarose gel electrophoresis of PCR products from a colony PCR of for addition of the BHBD CDS to the THL CDS, LacI promoter and RBS. Lane 1=1KB ladder. Lane 2-6 putative clones. (B) Agarose gel electrophoresis of digestion products of a positive clone. Lane 1=1 KB Ladder, Lane 2 Clone digest
Figure 5(A) shows colony of CRO ligated to BHBD, THL, the LacI promoter and RBS. Expected size was 1400 bp. Figure 5(B) shows the digest of a successful clone. It can be observed that the band size of the digest increases each time from the previous suggesting the addition of the new insert.
Figure 5: (A) Agarose gel electrophoresis of PCR products from a colony PCR of for addition of the CRO CDS to the BHBD,THL, LacI promoter and RBS. Lane 1=1KB ladder. Lane 2-9 putative clones. Only lanes 2,3, 4, 6 and 8 were successful. (B) Agarose gel electrophoresis of digestion products of two positive clones. Lane 1=1 KB Ladder, Lanes 2-3 Digested clones
Figure 6(A) shows colony of BCD ligated to CRO, BHBD, THL, the LacI promoter and RBS .Expected size was 1900 bp. Figure 6(B) shows the digest of a successful clone. It can be observed that the band size of the digest increases each time from the previous suggesting the addition of the new insert.
Figure 6: (A) Agarose gel electrophoresis of PCR products from a colony PCR of for addition of the BCD CDS to the CRO, BHBD,THL, LacI promoter and RBS. Lane 1=1KB ladder. Lane 2-3 putative clones. (B) Agarose gel electrophoresis of digestion products of two positive clones. Lane 1=1 KB Ladder, Lanes 2-3 digested clones
Figure 7(A) shows colony of EFb ligated to BCD, CRO, BHBD, THL, the LacI promoter and RBS. Expected size was 1500 bp. Figure 7 (B) shows the digest of a successful clone. It can be observed that the band size of the digest increases each time from the previous suggesting the addition of the new insert.
Figure 7: (A) Agarose gel electrophoresis of PCR products from a colony PCR of for addition of the EFb CDS to the CRO, BCD, BHBD,THL, LacI promoter and RBS. Lane 1=1KB ladder. Lane 2-9 putative clones. Only lanes 2,3, 5, 6, 7, 8 and 9 were successful. (B) Agarose gel electrophoresis of digestion products of a positive clone. Lane 1=1 KB Ladder, Lanes 2 Digested clone.
Figure 8(A) shows colony of EFa ligated to EFb, BCD, CRO, BHBD, THL, the LacI promoter and RBS. Expected size was 1550 bp.
Figure 8: (A) Agarose gel electrophoresis of PCR products from a colony PCR of for addition of the EFa CDS to the EFb, CRO, BCD, BHBD,THL, LacI promoter and RBS. Lane 1=1KB ladder. Lane 2-9 putative clones.
Measuring the production of butyryl coA in cultures of E. coli
AIM:
To determine if BioBricks containing the two pathways (i) BUK/PTB pathway (ii) THL/BHBD/CRO/BCD/EFb/EFa pathway could produce butyryl coA in E.coli fed with (i) acetate or (ii) butyric acid
METHOD:
High Pressure Liquid Chromatography (HPLC)
In order to analyse butyryl-CoA we used HPLC. Initial development was performed using reverse phase liquid chromatography with a C18 column 100mm x 4.6mm using UV detection at 250nm and various combinations of 0.1% formic acid and acetonitrile to obtain sufficient retention. This method was first tested on CoA and butyryl -CoA standards but no peak for CoA or butyl-CoA could be seen using this mobile phase combination. The 0.1% formic acid was replaced with water to provide a higher pH to see if this would improve the chromatography. Again no peak was seen. We suspected that the compounds may have been sensitive to active sites within the HPLC system so the water was replaced with 0.1M ammonium acetate. This resulted in a sharp peak of reasonable retention for both CoA and butyl-CoA. The final parameters used are listed below
Column: Luna C18 3µm 100mm x 4.6mm
Detection: UV @ 250nm
Mobile phase:
Mobile phase A: 0.1M ammonium acetate
Mobile phase B: Acetonitrile
| Time | %A | %B | Flow (mL/min) |
|---|---|---|---|
| 0 | 95 | 5 | 1 |
| 5 | 60 | 40 | 1 |
| 6 | 30 | 70 | 1 |
| 7 | 30 | 70 | 1 |
| 7.5 | 95 | 5 | 1 |
| 10 | 95 | 5 | 1 |
Extracts from cultures of E. coli containing the BioBricks for either pathway were analysed under these conditions but, due to the presence of many other peaks, it was not possible to determine if butyl-CoA was present. For this reason we decided use Mass Spectrometry (MS) to aid detection. Analysis was transferred to a Shimadzu single quadrupole LC/MS (Liquid Chromatograph/Mass Spectrometer) instrument. The column used had the same stationary phase but was 2.0mm in diameter to allow a lower flow rate of 0.4mL/min to be used, being more suitable for operation with the MS. The concentration of the ammonium acetate was reduced to 0.05M. The MS was operated in selected ion mode to increase sensitivity, monitoring masses 838 and 836 for +ve and –ve electrospray ionisation of the butyryl -CoA
Sample preparation
Plasmids were transformed into E.coli BL21 overexpression strain and expression was induced with IPTG overnight. Cells containing BUK/PTB were fed butyric acid to a final concentration of 50 mM and glycerol to a final concentration of 15%. The six gene pathway was fed with sodium acetate to a final concentration of 33mM and glycerol to a final concentration of 15%. To analyse only the intracellular metabolites cells were cooled on ice, centrifuged at 5000 rpm at 4°C. The supernatant was discarded and pellets were re-suspended in 1mL of 6% perchloric acid. After re-suspension, 0.3 ml of 3M K2C03 was added and the cells were vortexed. Cells were centrifuged at 1300 rpm for one minute and the supernatant was filter-sterilised. Filtered supernatant was analysed through HPLC following the protocol described above.
RESULTS:
In order to analyse the butyryl-CoA we first had to run the standards to observe at what time butyryl-CoA was retained. The results for the retention time of butyryl-CoA are shown in Figure 1.
The first sample that was analysed was the BUK/PTB pathway, the result are shown in Figure 2.
Figure 2 No peak is formed at 2.90 minutes when the BUK/PTB sample is analysed. This suggests that no butyryl-CoA is produced or that it below the detection limit.
Figure 1: shows the retention time of the butyryl-CoA standard that corresponds to 2.9 minutes.
Figure 2: Showing that at the time of 2.90 minutes when the butyryl-CoA standard is retained, (top) nothing is shown for the BUK/PTB pathway (bottom)
Compared to the control (Figure 3), there are no obvious differences.
Figure 3: Showing that at the time of 2.90 minutes when the butyryl-CoA standard is retained, (top) nothing is shown for the BUK/PTB pathway control (bottom)
Figure 4 shows the results for the six-gene pathway compared to the butyryl-CoA standard.
Figure 4: showing the THL/BHBD/CRO/BHBD/BCD/EFb/EFa HPLC retention time for butyryl-CoA at 2.90 minutes (botton) when the butyryl-CoA standard is retained (top).
From Figure 4 (bottom) it can be seen that a small peak forms just after 2.90 minutes but this is not significant.
From this preliminary experiment we conclude that the next step is to find the optimum conditions for growth and induction based on both the amount and concentration of butyric acid/sodium acetate used and to use mass spectrometry to correlate the exact mass of butyryl-CoA from the BUK/PTB pathway to the butyryl-CoA standard. We would also need to check each of the individual genes in the pathway to check that they are functional and also determine if the pathway is being blocked at any intermediate step.
Title Last
AIM:
METHOD:
RESULTS:
Figure 1:
Figure 2:
